Showing results (221-230 of 250) with videos related to
Sort By:
Pageof 25
Investigational New Drugs|September 1, 2005
Phase I/II trial of pyrazoloacridine and carboplatin in patients with recurrent glioma: a North Central Cancer Treatment Group trialEvanthia Galanis, Jan C Buckner, Matthew J Maurer, et al.International Journal of Radiation Oncology, Biology, Physics|December 24, 2005
Spinal cord gliomas: A multi-institutional retrospective analysisMay Abdel-Wahab, Blessing Etuk, James Palermo, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 12, 2002
Risk of cancer among relatives of patients with gliomaBrian P O'Neill, Hannes Blondal, Ping Yang, et al.Neuro-Oncology|June 27, 2002
Prognostic significance of an apoptotic index and apoptosis/proliferation ratio for patients with high-grade astrocytomasHiroko Kuriyama, Kathleen R Lamborn, Judith R O'Fallon, et al.Journal of Neuro-Oncology|December 11, 2008
Phase II trial of two different irinotecan schedules with pharmacokinetic analysis in patients with recurrent glioma: North Central Cancer Treatment Group resultsMarta Santisteban, Jan C Buckner, Joel M Reid, et al.Plos Medicine|February 20, 2009
Donor-derived brain tumor following neural stem cell transplantation in an ataxia telangiectasia patientNinette Amariglio, Abraham Hirshberg, Bernd W Scheithauer, et al.Journal of the Peripheral Nervous System : JPNS|November 3, 2010
Inflammatory pseudotumor of nerve: clinicopathological characteristics and a potential therapyMichelle L Mauermann, Bernd W Scheithauer, Robert J Spinner, et al.The American Journal of Surgical Pathology|March 27, 2003
Primary anaplastic large cell lymphoma of the central nervous system: prognostic effect of ALK-1 expressionDavid H George, Bernd W Scheithauer, Fügen V Aker, et al.Laboratory Investigation; a Journal of Technical Methods and Pathology|August 20, 2008
Immunoglobulin derived depositions in the nervous system: novel mass spectrometry application for protein characterization in formalin-fixed tissuesFausto J Rodriguez, Jeffrey D Gamez, Julie A Vrana, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 15, 2003
Phase II trial of procarbazine, lomustine, and vincristine as initial therapy for patients with low-grade oligodendroglioma or oligoastrocytoma: efficacy and associations with chromosomal abnormalitiesJan C Buckner, Dean Gesme, Judith R O'Fallon, et al.Pageof 25